Personalized treatment for smoking cessation in primary care
Official title: A Multilevel Intervention to Personalize and Improve Tobacco Treatment in Primary Care (MOTIVATE)
Run by Washington University School of Medicine · NCT05846841 · Data updated 2026-11-12
This study is testing a personalized approach to help people quit smoking in primary care to see if it works better than the usual methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 850 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | September 29, 2023 |
| Main results expected | March 31, 2028 |
| Study ends | September 30, 2028 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT05846841 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are current smokers and willing to consider medication for smoking cessation.
✕Probably not a fit
Patients who have recently used smoking cessation medications or have contraindications for such treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a precision treatment intervention for smoking cessation, comparing its effectiveness to usual care in primary care settings. It utilizes personalized recommendations based on patients' clinical, genetic, and biomarker information to enhance treatment adherence and clinician prescribing practices. The study involves a 2-arm cluster randomized controlled trial with 50 clinicians and 800 eligible patients, aiming to assess the impact of precision treatment on smoking cessation success. The goal is to address gaps in both clinician and patient engagement with tobacco treatment.
Why it matters
Potential benefit: If successful, this approach could significantly improve smoking cessation rates among patients by providing tailored treatment options.
How similar studies have gone: Other studies have shown promise in using precision medicine approaches for smoking cessation, indicating potential for success in this novel intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Eligibility Criteria for Primary and Specialty Care Clinicians * Clinician from participating clinic * At least 18 years of age * Can speak and understand English Eligibility Criteria for Primary Care and Specialty Patients Inclusion: * Patient at participating clinic * Age 18 years or older, inclusive * Current smoking (cigarettes per day \>=5) * Can speak and understand English * Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline Exclusion: * Active use of smoking cessation medication (within the past 30 days) * Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days) * Having a contraindication for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)
Where it's running
-
Washington University School of Medicine
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Li-Shiun Chen, ScD, MD, MPH — Washington University School of Medicine
- Study coordinator: Li-Shiun Chen, ScD, MD, MPH
- Email: li-shiun@wustl.edu
- Phone: 314-362-3932
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized treatment to help people with cancer quit smoking and live longer
We will test whether personalized tobacco treatment using clinical, genetic, and biomarker information helps cancer patients who smoke quit and use cessation medications more than usual care.
-
Actívatexto: Helping Latinos quit smoking and become more active
This trial tests whether Actívatexto, a text-message program combined with wearables and nicotine replacement, helps Latino adults who smoke quit and increase their physical activity.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
Technology-based motivational interviewing to help adults quit smoking
This project will try a chatbot-based motivational interviewing coach to help adult primary care patients who smoke become ready to quit and create a personalized quit plan.
-
Using an air quality monitor to encourage smoke-free homes for cancer patients
This study is testing if using an air quality monitor can help cancer patients who smoke create smoke-free homes and quit smoking.
-
Proactive tobacco treatment for household smokers through pediatric care
This study is testing a new way to help household smokers quit tobacco by using support from pediatric care to see if it can improve their chances of success.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.